When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
HRTX - FDA rejects Heron Therapeutics' NDA for HTX-011 for postoperative pain
Heron Therapeutics Inc.
Heron Therapeutics (NASDAQ:HRTX) is down 11% premarkket in reaction to its announcement that it received a Complete Response Letter (CRL) from the FDA regarding its NDA for HTX-011 for the management of postoperative pain.
More news on: Heron Therapeutics, Inc., Healthcare stocks news, Stocks on the move,